Heart Failure: A Companion To Braunwald’s Heart Disease (4th Edition)

DescriptionUp-to-date, authoritative and comprehensive, Heart Failure, 4th Edition, provides the clinically relevant information you need to effectively manage and treat patients with this complex cardiovascular problem. This fully revised companion to Braunwald’s Heart Disease helps you make the most of new drug therapies such as angiotensin receptor neprilysin inhibitors (ARNIs), recently improved implantable devices, and innovative patient management strategies. Led by internationally recognized heart failure experts Dr. G. Michael Felker and Dr. Douglas Mann, this outstanding reference gives health care providers the knowledge to improve clinical outcomes in heart failure patients.Table of ContentsSection 1 Basic Mechanisms of Heart FailureMolecular Basis for Heart FailureCellular Basis for Heart FailureCellular Basis for Myocardial Regeneration and RepairMyocardial Basis for Heart Failure: Role of Cardiac InterstitiumSection 2 Mechanisms of Disease Progression in Heart FailureMolecular Signaling Mechanisms of the Renin-Angiotensin System in Heart FailureAdrenergic Receptor Signaling in Heart FailureRole of Innate Immunity in Heart FailureOxidative Stress in Heart FailureNatriuretic Peptides in HFSystolic Dysfunction in Heart FailureAlterations in Ventricular Function: Diastolic Heart FailureAlterations in Ventricular Structure: Role of Left Ventricular Remodeling and Reverse Remodeling in Heart FailureAlterations in the Sympathetic and Parasympathetic Nervous Systems in Heart FailureAlterations in the Peripheral Circulation in Heart FailureAlterations in Kidney Function Associated with Heart FailureAlterations in Skeletal Muscle in Heart FailureAlterations in Cardiac MetabolismSection 3 Etiological Basis for Heart FailureEpidemiology of Heart FailureHeart Failure as a Consequence of Ischemic Heart DiseasHeart Failure as a Consequence of Dilated CardiomyopathyThe Restrictive and Infiltrative Cardiomyopathies and Arrhythmogenic Right Ventricular Dysplasia/CardiomyopathyCardiac AmyloidosisHeart Failure as a Consequence of Hypertrophic CardiomyopathyHeart Failure as a Consequence of Genetic CardiomyopathyHeart Failure as a Consequence of HypertensionHeart Failure as a Consequence of Valvular Heart DiseaseHeart Failure as a Consequence of Congenital Heart DiseaseHeart Failure as a Consequence of Viral and Nonviral MyocarditisHeart Failure in the Developing WorldHeart Failure and Human Immunodeficiency VirusSection 4 Clinical Assessment of Heart FailureClinical Evaluation of Heart FailureCardiac Imaging in Heart FailureBiomarkers and Precision Medicine in Heart FailureHemodynamics in Heart FailureSection 5 Therapy for Heart FailureDisease Prevention in Heart FailureManagement of Acute Decompensated Heart FailureGuidelinesContemporary Medical Therapy for Heart Failure Patients with Reduced Ejection FractionGuidelines: Management of Heart Failure with a Reduced Ejection FractionManagement of Arrhythmias and Device Therapy in Heart FailureGuidelinesTreatment of Heart Failure with Preserved Ejection FractionGuidelinesManagement of Heart Failure in Special Populations: Older Patients, Women, and Racial/Ethnic Minority GroupsGene and Stem-Cell Based Therapies in Heart FailureNeuromodulation in Heart FailurePulmonary HypertensionCardiac TransplantationCirculatory Assist Devices in Heart FailureCardio-Oncology and Heart FailureDisease Management and Telemedicine in Heart FailureManagement of Comorbidities in Heart FailureQuality and Outcomes in Heart FailureDecision Making and Palliative Care in Advanced Heart FailureAuthors BiographyG. Michael FelkerAffiliations and ExpertiseProfessor of Medicine, Chief, Heart Failure Section, Division of Cardiology, Director, Clinical Research Unit, Duke Heart Center, Director of Heart Failure Research, Duke Clinical Research Institute, Durham, North CarolinaDouglas MannAffiliations and ExpertiseLewin Chair and Professor of Medicine and Professor of Cell Biology and Physiology at Washington University in St Louis, Missouri